CRISPR-based genome editing has transformed biological research. Since the advent of the technology in 2012, Addgene has ...
In a groundbreaking fusion of artificial intelligence and gene editing, researchers are leveraging machine learning to enhance CRISPR technology’s precision and efficiency. This integration is opening ...
In the never-ending quest to discover previously unknown CRISPR gene-editing systems, researchers have scoured microbes in everything from hot springs and peat bogs to poo and even yogurt. Now, thanks ...
Genome editing has advanced at a rapid pace with promising results for treating genetic conditions-but there is always room for improvement. A new paper by investigators from Mass General Brigham ...
Creative Biolabs updates its CRISPR-based gene editing and customized donor vector construction services to accelerate disease modeling and targeted gene therapy research worldwide.
“Ten years ago, it was super hard to think about targeting individual genes. And now that’s something, with these kinds of CRISPR screens, we can do routinely,” said Neville Sanjana, a geneticist at ...
Scientists used CRISPR to disable the NRF2 gene, restoring chemotherapy sensitivity in lung cancer cells and slowing tumor growth. The technique worked even when only a fraction of tumor cells were ...
Clustered regularly interspaced short palindromic repeats (CRISPR) and CRISPR-associated (Cas) proteins are core components of fast-evolving therapeutic gene editing tools. Scientists have used CRISPR ...
Although outbreaks of Ebola virus are rare, the disease is severe and often fatal, with few treatment options. Rather than targeting the virus itself, one promising therapeutic approach would be to ...
Beam Therapeutics' (BEAM +4.01%) base-editing approach enables the company to rewrite a single letter of the genome. While other CRISPR methods are similar to genetic scissors, base editing is more ...
The benefits of investing in CRISPR gene-editing ETFs include: Significant long-term potential for CRISPR technology. Diversification across multiple stocks focused on CRISPR gene editing. Less ...